Cohort study of carcinogenesis of hepatocellular carcinoma in nonalcoholic fatty liver disease
Not Applicable
- Conditions
- nonalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000021810
- Lead Sponsor
- Department of Gastroenterology and Hepatology Yokohama City University School of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. MRI examination is impossible (ex. Installation of pacemaker, claustrophobia) 2. Pregnant patients 3. In the opinion of the investigator, patient is unsuitable as a study subject.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To elucidate the risk factor of carcinogenesis of HCC by assessing time-dependent change of liver pathogenesis by using MR elastography and transient elastgraphy.
- Secondary Outcome Measures
Name Time Method To elucidate the risk factor of carcinogenesis of HCC by hematological examination and therapeutic situation of lifestyle-related diseases.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link NAFLD progression to HCC carcinogenesis in JPRN-UMIN000021810 cohort study?
What are the key differences in HCC development between NAFLD and NASH subtypes in the JPRN-UMIN000021810 study?
Which non-invasive biomarkers predict HCC progression in NAFLD patients from JPRN-UMIN000021810?
What are the optimal surveillance protocols for HCC in NAFLD patients based on JPRN-UMIN000021810 findings?
How do antidiabetic agents like GLP-1 agonists influence HCC risk in NAFLD cohorts?